Heron Therapeutics And HTX-011 Are Both Severely Undervalued Seeking Alpha, 09 Aug 2016 , Heron Therapeutics (NASDAQ: HRTX ) announced preliminary, positive, top-line efficacy results from two Phase 2 studies of HTX-0…